市場調查報告書
商品編碼
1541734
2024-2032 年按技術(乳房斷層合成、CAD、數位)、產品(膠片螢幕系統、數位系統、模擬系統、活體組織切片系統、3D 系統)和區域分類的乳房 X 光攝影市場報告Mammography Market Report by Technology (Breast Tomosynthesis, CAD, Digital), Product (Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems), and Region 2024-2032 |
IMARC Group年,全球乳房X光攝影市場規模達25億美元。
乳房X光檢查是一種非侵入性醫學影像和診斷程序,使用低劑量X光篩檢乳房組織中的惡性腫瘤細胞。乳房X光檢查或乳房X光檢查使用模擬、數位、電腦輔助檢測和斷層合成系統來突出顯示乳房中的小腫瘤、囊腫和其他不規則現象。進行乳房X光檢查是為了在沒有任何症狀的情況下檢查是否有異常,這有助於及時治療嚴重的醫療狀況。通常隨後進行診斷性乳房X光檢查以評估任何異常的臨床發現。因此,它在醫院、專科診所以及診斷和門診手術中心中得到了廣泛的應用。
全球乳癌盛行率不斷上升是推動市場成長的關鍵因素之一。此外,大眾對現有治療替代方案以及乳癌篩檢和早期診斷益處的認知不斷提高,這也推動了市場成長。此外,各種技術進步,例如創新的3D、非電離和電離成像解決方案的開發,也是其他成長誘導因素。例如,全視野數位乳房 X 光攝影 (FFDM) 和數位乳房斷層合成 (DBT) 系統從多個角度捕捉大量乳房影像,並將它們整合到 3D 影像集中,以產生更高精度的結果。與此一致,為公立醫院和診斷中心提供具有成本效益的影像解決方案的數位乳房X光檢查系統租賃服務也有助於市場的成長。其他因素,包括醫療基礎設施的顯著改善,以及促進公共衛生的有利政府政策的實施,預計將推動市場成長。
The global mammography market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Mammography refers to a non-invasive medical imaging and diagnostic procedure that uses low-dose X-rays to screen breast tissues for malignant tumor cells. A mammography exam, or mammogram, uses analog, digital, computer-aided detection and tomosynthesis systems to highlight small tumors, cysts and other irregularities in the breasts. Screening mammography is conducted to check for abnormalities in the absence of any symptoms, which can aid in timely treatment of a serious medical condition. It is usually followed by a diagnostic mammogram to evaluate any abnormal clinical findings. As a result, it finds extensive applications in hospitals, specialty clinics and diagnostic and ambulatory surgical centers.
The increasing prevalence of breast cancer across the globe is one of the key factors driving the growth of the market. Moreover, increasing awareness regarding the available treatment alternatives and the benefits of screening and early diagnosis of breast cancer among the masses is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative 3-Dimentional, non-ionizing and ionizing imaging solutions, are acting as other growth-inducing factors. For instance, Full-field digital mammography (FFDM) and Digital Breast Tomosynthesis (DBT) systems capture numerous images of the breast from multiple angles and integrates them into a 3D image set for the generation of results with enhanced precision. In line with this, the availability of rental services for digital mammography systems for public hospitals and diagnostic centers providing cost-effective imaging solutions is also contributing to the growth of the market. Other factors, including significant improvements in the healthcare infrastructure, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global mammography market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and product.
Breast Tomosynthesis
CAD
Digital
Film Screen Systems
Digital Systems
Analog Systems
Biopsy Systems
3D Systems
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Analogic Corporation, Carestream Health (Onex Corporation), Fujifilm Holdings Corporation, General Electric Company, Hologic Inc., Konica Minolta Inc., Metaltronica S.p.A., Mindray Medical International Limited, Koninklijke Philips N.V., Planmed Oy (Planmeca Oy) and Siemens AG.